STK-001

STK-001 · Stoke Therapeutics

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for STK-001, covering 2025-05-18 to 2026-02-04. Get the full timeline:

Most recent: Clinical Trial Update: An Open-Label Extension Study of STK-001 for Patients With Dravet Syndrome [Phase 2]